Xianzhang Bu

sun yat-sen university

H指数:0

被引数:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels (vol 42, pg 1840, 2010)

丁酸钠在转录和转录后水平下调色氨酸2,3-双加氧酶(vol 42, pg 1840, 2010)

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

IF2.8

2026-08-010

PRE

Targeting phagocytosis for amyloid-β clearance: implications of morphology remodeling and microglia activation probed by bifunctional chimaeras

靶向吞噬作用以清除淀粉样蛋白-β：通过双功能嵌合体探查形态重塑和小胶质细胞活化的意义

Nature Communications

IF15.7

2025-08-300

OAAI

Targeting the TRIM14/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC

靶向TRIM14/USP14轴通过诱导GPX4降解和破坏铁死亡防御来增强放射治疗疗效在肝癌中。

Cell Death & Disease

IF9.6

2025-07-010

OAAI

Nilotinib in combination with sunitinib renders MCL-1 for degradation and activates autophagy that overcomes sunitinib resistance in renal cell carcinoma

尼洛替尼与舒尼替尼联合MCL-1降解并激活自噬，从而克服肾细胞癌中的舒尼替尼耐药性

CELLULAR ONCOLOGY

IF4.8

2024-02-231

PRE

Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+

BIOCHEMICAL PHARMACOLOGY

IF5.6

2023-05-015

PRE

N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis

MOLECULAR THERAPY

IF12

2023-02-0137

OAAI

Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination

CELLULAR ONCOLOGY

IF4.8

2022-10-075

PRE

Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradation

DEPTOR的稳定通过靶向降解使下咽癌对放射治疗敏感

MOLECULAR THERAPY ONCOLYTICS

IF5.3

2022-09-012

OAAI

Synthesis and evaluation of anticancer activity of BOC26P, an ortho-aryl chalcone sodium phosphate as water-soluble prodrugs in vitro and in vivo

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2017-12-0111

PREAI

Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase

BIOCHEMICAL PHARMACOLOGY

IF5.6

2017-08-0116

PREAI

MC37, a new mono-carbonyl curcumin analog, induces G2/M cell cycle arrest and mitochondria-mediated apoptosis in human colorectal cancer cells

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2017-02-0133

PREAI

Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2016-06-2181

PREAI

Inhibitory effect of flavonoids on human glutaminyl cyclase

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2016-05-0126

PREAI

Mitochondria-Targeted Approach: Remarkably Enhanced Cellular Bioactivities of TPP2a as Selective Inhibitor and Probe toward TrxR

ACS CHEMICAL BIOLOGY

IF3.8

2015-12-1443

PREAI

FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells

CELLULAR SIGNALLING

IF3.7

2015-03-01152

PREAI

A new tumor vaccine FAPτ-MT elicits effective antitumor response by targeting indolamine-2,3-dioxygenase in antigen presenting cells

CANCER BIOLOGY & THERAPY

IF4.6

2014-10-2719

OAAI

Discovery of Potent Cytotoxic Ortho-Aryl Chalcones as New Scaffold Targeting Tubulin and Mitosis with Affinity-Based Fluorescence

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2014-07-2549

PREAI

A furanyl acryl conjugated coumarin as an efficient inhibitor and a highly selective off-on fluorescent probe for covalent labelling of thioredoxin reductase

CHEMICAL COMMUNICATIONS

IF4.2

2014-01-0138

PREAI

Deubiquitinase Inhibition of 19S Regulatory Particles by 4-Arylidene Curcumin Analog AC17 Causes NF-κB Inhibition and p53 Reactivation in Human Lung Cancer Cells

MOLECULAR CANCER THERAPEUTICS

IF5.5

2013-08-0865

OAAI

Synthesis and Identification of New Flavonoids Targeting Liver X Receptor β Involved Pathway as Potential Facilitators of Aβ Clearance with Reduced Lipid Accumulation

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2013-07-2624

PRE

Xianzhang Bu

个人简介

教育背景

工作经历

荣誉奖项

研究方向